Sascha Barabas

An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity

Sascha Barabas, Theresa Spindler, Richard Kiener et al. · BMC Immunology · 2017 · 68 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation

Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke et al. · Haematologica · 2019 · 52 citations · Full text

Life Sciences, Hematology, Immunology +11

Characterization of the<i>Helicobacter pylori</i>Cysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent

Ludwig Deml, Michael Aigner, Jochen Decker et al. · Infection and Immunity · 2005 · 45 citations · Full text

Veterinary Medicine, Immunology, Microbiology +17

Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients

Bernhard Banas, Carsten A. Böger, Gerhard Lückhoff et al. · BMC Immunology · 2017 · 40 citations · Full text

Medicine, Immunology, Nephrology +15

Clinical validation of a novel enzyme-linked immunosorbent spot assay-based<i>in vitro</i>diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study

Bernhard Banas, Dominik Steubl, Lutz Renders et al. · Transplant International · 2017 · 37 citations · Full text

Life Sciences, Immunology, Nephrology +17